Quarterly ResultMay 14, 2026, 10:32 AM
Bodhi Tree Biotechnology Q1 Net Loss $(29,195); Cash $22,750
AI Summary
Bodhi Tree Biotechnology Inc. reported a net loss of $(29,195) for the three months ended March 31, 2026, an improvement from $(53,428) year-over-year, with revenue increasing to $15,000 from nil. For the six months, net loss decreased to $(82,144) from $(118,205). However, the company's cash balance significantly declined to $22,750 from $109,404, and total stockholders' equity decreased to $37,017. Management also identified material weaknesses in internal controls over financial reporting.
Key Highlights
- Net loss for three months ended March 31, 2026, was $(29,195), an improvement from $(53,428) YoY.
- Revenue for three months ended March 31, 2026, was $15,000, up from $0 YoY.
- Net loss for six months ended March 31, 2026, was $(82,144), an improvement from $(118,205) YoY.
- Cash balance as of March 31, 2026, decreased to $22,750 from $109,404 in Sep 2025.
- Total stockholders' equity decreased to $37,017 from $119,161 in Sep 2025.
- Accumulated deficit increased to $(293,763) as of March 31, 2026.
- Identified material weaknesses in internal controls over financial reporting.
- All revenue for the six months ended March 31, 2026, came from one customer.